Activity Tracking Study in Healthy Volunteers (MK-0000-419)
A Pilot Study to Evaluate the Use of a Wrist-worn Accelerometer Device for Physical Activity Monitoring in Healthy Volunteers
2 other identifiers
interventional
12
1 country
2
Brief Summary
In this study, researchers want to learn if a watch can be used to track physical activity in healthy people. The watch will collect the data and send it to a database using a data storage device. The goal of this study is to measure:
- The number of people who wear the watch as instructed
- The number of working watches and data storage devices returned at the end of the study
- The number of watches that successfully sent data back to a database
- The overall daily activity for people including the number of daily steps taken and how much time is spent doing non-exercise activity and mild to intense exercise.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_1 healthy
Started May 2022
Shorter than P25 for phase_1 healthy
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 12, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 16, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 16, 2022
CompletedFirst Submitted
Initial submission to the registry
February 13, 2025
CompletedFirst Posted
Study publicly available on registry
February 19, 2025
CompletedFebruary 19, 2025
February 1, 2025
1 month
February 13, 2025
February 13, 2025
Conditions
Outcome Measures
Primary Outcomes (7)
Number of Participants that Wear Watch as Instructed
The number of participants that wear the watch for at least 19.2 hours per day (80% of the time) will be reported.
Up to approximately 2 weeks
Number of Provisioned Watches and Data Storage Devices That Were Returned
The number of watches and data storage devices provisioned and returned free from malfunction will be reported.
Up to approximately 2 weeks
Number of Watches and Data Storage Devices that Successfully Transmit Data
The number of watches and data storage devices that successfully transmit data to central database will be reported.
Up to approximately 2 weeks
Average Daily Overall Activity Count
The average daily overall activity will be reported.
Up to approximately 2 weeks
Average Daily Total Step Count
The number of average daily total steps will be reported.
Up to approximately 2 weeks
Average Daily Time (minutes) in Nonsedentary Activity
The average daily time spent in nonsedentary activity will be reported.
Up to approximately 2 weeks
Average Daily Time (minutes) in Moderate-to-Vigorous Physical Activity
The average daily time spent in moderate-to-vigorous physical activity will be reported.
Up to approximately 2 weeks
Secondary Outcomes (2)
Number of Participants Who Experience an Adverse Event (AE)
Up to approximately 2 weeks
Number of Participants Who Discontinue Study Intervention Due to an AE
Up to approximately 2 weeks
Study Arms (1)
Watch Wearing to Track Activity
EXPERIMENTALParticipants wear a watch that tracks physical activity throughout study.
Interventions
Device includes a wristwatch that tracks physical activity and a data storage unit that transmits data to a central database.
Eligibility Criteria
You may qualify if:
- Is in good health
- Is willing to comply with study restrictions
You may not qualify if:
- History of clinically significant endocrine, GI, cardiovascular, hematological, hepatic, immunological, renal, respiratory, genitourinary, or major neurological (including stroke and chronic seizures) abnormalities or diseases
- History of cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
QPS-MRA, LLC (Site 0001)
South Miami, Florida, 33143, United States
Altasciences Clinical Kansas, Inc. (Site 0002)
Overland Park, Kansas, 66212, United States
Related Links
Study Officials
- STUDY DIRECTOR
Medical Director
Merck Sharp & Dohme LLC
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 13, 2025
First Posted
February 19, 2025
Study Start
May 12, 2022
Primary Completion
June 16, 2022
Study Completion
June 16, 2022
Last Updated
February 19, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will share
http://engagezone.msd.com/doc/ProcedureAccessClinicalTrialData.pdf